This is the limited version of the VaxGen company profile: Join LinkedIn or Sign In to see more information.
VaxGen, Inc., a biopharmaceutical company, engages in the development, manufacture, and commercialization of biologic products for the prevention and treatment of human infectious disease. It focuses on the development and commercialization of biologic products to counter potential bioterrorism threats, primarily vaccines for the long-term prevention of anthrax and smallpox. The company, in collaboration with the Chemo-Sero-Therapeutic Research Institute of Japan, is developing LC16m8, a smallpox vaccine candidate. VaxGen was founded in 1995 and is based in South San Francisco, California.
Your Connections to VaxGen
Popular Profiles at VaxGen
349 Oyster Point Boulevard
South San Francisco, CA
94080
United States
Phone: 650-624-1000
Fax: 650-624-1001
| Headquarters | San Francisco Bay Area |
| Industry | Biotechnology |
| Type | Public Company |
| Status | Operating |
| Company Size |
201-500 employees |
| 2006 Revenue |
$15
mil
|
| Founded | 1995 |
| Website | http://www.vaxgen.com |
| Top Schools |
| San Francisco St. Univ. | 17% |
|
Estimated based on LinkedIn Data
Career path for VaxGen employees